STAT

FDA approves first gene therapy targeting rare form of inherited blindness

BREAKING: FDA approves a first-of-its-kind gene therapy to treat a rare, inherited form of childhood blindness.

A first-of-its-kind gene therapy received approval from the Food and Drug Administration on Tuesday to treat a rare, inherited form of childhood blindness.

The FDA marketing clearance of Spark Therapeutics’s  is historic for scientific and financial reasons. Luxturna is the first gene therapy approved in the U.S. that targets a disease caused by mutations in a specific gene.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Purdue Pharma, Maker Of OxyContin And Other Drugs, Files For Bankruptcy
Facing thousands of lawsuits alleging that it helped spark the opioid addiction crisis, privately held Purdue Pharma announced it had filed for bankruptcy,
STAT3 min readSociety
Opinion: A Dangerous View: Why It’s A Mistake For Medical Schools To Ignore Social Justice
An op-ed in the Wall Street Journal called for getting back to basics in medical school and forgoing teaching on gun violence or other social issues. The author has it…
STAT7 min read
Could Editing The DNA Of Embryos With CRISPR Help Save People Who Are Already Alive?
There is a little-discussed potential application of CRISPR: tweaking its DNA of embryos to help save someone who is already alive.